Global and Region Pneumonia Vaccine Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Center for Disease Control and Prevention (CDC) recommends administration of two pneumococcal vaccines.

    The report details the trend, potential and market size of Pneumonia Vaccine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Pneumonia Vaccinemarket, defines the market attractiveness level of Pneumonia Vaccine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Pneumonia Vaccine industry, describes the types of Pneumonia Vaccine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pneumonia Vaccine market and the development prospects and opportunities of Pneumonia Vaccine industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pneumonia Vaccine market in Chapter 13.

    By Player:

    • Johnson & Johnson

    • Emergent Biosolutions

    • Sanofi Pasteur

    • CSL Limited

    By Type:

    • Pneumococcal Conjugate Vaccine (PCV13)

    • Pneumococcal Polysaccharide Vaccine (PPSV23)

    By End-User:

    • Pneumonia

    • Meningitis

    • Sepsis

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Pneumonia Vaccine Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Pneumonia Vaccine Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Pneumonia Vaccine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Pneumonia Vaccine Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Pneumonia Vaccine Market Analysis and Outlook to 2022

    • 7.1 Global Pneumonia Vaccine Consumption (2017-2022)

    • 7.2 United States Pneumonia Vaccine Consumption (2017-2022)

    • 7.3 Europe Pneumonia Vaccine Consumption (2017-2022)

    • 7.4 China Pneumonia Vaccine Consumption (2017-2022)

    • 7.5 Japan Pneumonia Vaccine Consumption (2017-2022)

    • 7.6 India Pneumonia Vaccine Consumption (2017-2022)

    • 7.7 South Korea Pneumonia Vaccine Consumption (2017-2022)

    8 Region and Country-wise Pneumonia Vaccine Market Analysis and Outlook to 2028

    • 8.1 Global Pneumonia Vaccine Consumption Forecast (2022-2028)

    • 8.2 United States Pneumonia Vaccine Consumption Forecast (2022-2028)

    • 8.3 Europe Pneumonia Vaccine Consumption Forecast (2022-2028)

    • 8.4 China Pneumonia Vaccine Consumption Forecast (2022-2028)

    • 8.5 Japan Pneumonia Vaccine Consumption Forecast (2022-2028)

    • 8.6 India Pneumonia Vaccine Consumption Forecast (2022-2028)

    • 8.7 South Korea Pneumonia Vaccine Consumption Forecast (2022-2028)

    9 Global Pneumonia Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Pneumonia Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Pneumococcal Conjugate Vaccine (PCV13) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Pneumococcal Polysaccharide Vaccine (PPSV23) Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pneumonia Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pneumonia Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Meningitis Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Sepsis Consumption and Growth Rate (2017-2022)

    10 Global Pneumonia Vaccine Market Outlook by Types and Applications to 2028

    • 10.1 Global Pneumonia Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Pneumococcal Conjugate Vaccine (PCV13) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Pneumococcal Polysaccharide Vaccine (PPSV23) Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Pneumonia Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Pneumonia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Meningitis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Sepsis Consumption Forecast and Growth Rate (2022-2028)

    11 Global Pneumonia Vaccine Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Pneumonia Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Pneumonia Vaccine Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Pneumonia Vaccine Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Pneumonia Vaccine Market Competitive Analysis

    • 14.1 Johnson & Johnson

      • 14.1.1 Johnson & Johnson Company Details

      • 14.1.2 Johnson & Johnson Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Johnson & Johnson Pneumonia Vaccine Product and Service

    • 14.2 Emergent Biosolutions

      • 14.2.1 Emergent Biosolutions Company Details

      • 14.2.2 Emergent Biosolutions Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Emergent Biosolutions Pneumonia Vaccine Product and Service

    • 14.3 Sanofi Pasteur

      • 14.3.1 Sanofi Pasteur Company Details

      • 14.3.2 Sanofi Pasteur Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Sanofi Pasteur Pneumonia Vaccine Product and Service

    • 14.4 CSL Limited

      • 14.4.1 CSL Limited Company Details

      • 14.4.2 CSL Limited Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 CSL Limited Pneumonia Vaccine Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Pneumonia Vaccine

    • Figure Pneumonia Vaccine Picture

    • Table Global Pneumonia Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pneumonia Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pneumonia Vaccine Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Pneumonia Vaccine Consumption by Country (2017-2022)

    • Figure United States Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure China Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Pneumonia Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pneumococcal Conjugate Vaccine (PCV13) Consumption and Growth Rate (2017-2022)

    • Figure Global Pneumococcal Polysaccharide Vaccine (PPSV23) Consumption and Growth Rate (2017-2022)

    • Figure Global Pneumonia Consumption and Growth Rate (2017-2022)

    • Figure Global Meningitis Consumption and Growth Rate (2017-2022)

    • Figure Global Sepsis Consumption and Growth Rate (2017-2022)

    • Figure Global Pneumococcal Conjugate Vaccine (PCV13) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pneumococcal Polysaccharide Vaccine (PPSV23) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pneumonia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Meningitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sepsis Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Pneumonia Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Pneumonia Vaccine Export by Region (Top 5 Countries) (2017-2028)

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Pneumonia Vaccine Product and Service

    • Table Emergent Biosolutions (Foundation Year, Company Profile and etc.)

    • Table Emergent Biosolutions Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emergent Biosolutions Pneumonia Vaccine Product and Service

    • Table Sanofi Pasteur (Foundation Year, Company Profile and etc.)

    • Table Sanofi Pasteur Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur Pneumonia Vaccine Product and Service

    • Table CSL Limited (Foundation Year, Company Profile and etc.)

    • Table CSL Limited Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Limited Pneumonia Vaccine Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.